XML 28 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss)
Treasury Stock, Common
Cash dividends declared:              
Shareholders’ equity $ 2,258,942   $ 1,640,358 $ 837,473   $ (433) $ (218,456)
Beginning Balances at Dec. 31, 2021 2,258,942   $ 1,640,358 837,473   (433) $ (218,456)
Beginning Balances at Dec. 31, 2021     104,281,794       (10,132,554)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 217,612     217,612      
Other comprehensive loss (358,230)         (358,230)  
Cash dividends declared:              
Common Stock at $0.92 per share in 2022, $0.92 per share in 2023, and $0.94 per share in 2024 (86,848)     (86,848)      
Exercise of stock options, net of shares purchased (in shares)             15,660
Exercise of stock options, net of shares purchased (177)   $ (160)       $ (337)
Restricted stock awards, net of forfeitures (in shares)             726,199
Restricted stock awards, net of forfeitures (3,659)   (18,972)       $ 15,313
Share-based compensation expense 13,379   $ 13,379        
Ending Balances (in shares) at Dec. 31, 2022     104,281,794       (9,390,695)
Ending Balances at Dec. 31, 2022 2,041,373   $ 1,634,605 968,237   (358,663) $ (202,806)
Cash dividends declared:              
Shareholders’ equity 2,041,373   1,634,605 968,237   (358,663) $ (202,806)
Net income 255,863     255,863      
Other comprehensive loss 48,844         48,844  
Common Stock at $0.92 per share in 2022, $0.92 per share in 2023, and $0.94 per share in 2024 (87,382)     (87,382)      
Exercise of stock options, net of shares purchased (in shares)             4,855
Exercise of stock options, net of shares purchased (48)   (57)       $ (105)
Restricted stock awards, net of forfeitures (in shares)             245,290
Restricted stock awards, net of forfeitures (5,670)   (10,474)       $ 4,804
Share-based compensation expense 14,898   $ 14,898        
Ending Balances (in shares) at Dec. 31, 2023     104,281,794       (9,140,550)
Ending Balances at Dec. 31, 2023 2,267,974 $ 599 $ 1,638,972 1,136,718 $ 599 (309,819) $ (197,897)
Cash dividends declared:              
Shareholders’ equity 2,267,974 $ 599 1,638,972 1,136,718 $ 599 (309,819) $ (197,897)
Net income 228,830     228,830      
Other comprehensive loss 20,020         20,020  
Common Stock at $0.92 per share in 2022, $0.92 per share in 2023, and $0.94 per share in 2024 (89,818)     (89,818)      
Restricted stock awards, net of forfeitures (in shares)             353,596
Restricted stock awards, net of forfeitures (5,257)   (12,610)       $ 7,353
Share-based compensation expense 15,693   $ 15,693        
Ending Balances (in shares) at Dec. 31, 2024     104,281,794       (8,786,954)
Ending Balances at Dec. 31, 2024 2,438,041   $ 1,642,055 1,276,329   (289,799) $ (190,544)
Cash dividends declared:              
Shareholders’ equity $ 2,438,041   $ 1,642,055 $ 1,276,329   $ (289,799) $ (190,544)